收藏切换
Research Progress on Mechanism of Sanqi (Panax notoginseng) Saponins in Treatment of Osteoporosis
收藏切换
Peng WANG1, Longcan LI2, Fayan WEN2, Xingwen XIE3, Yanjun ZHANG1
Chinese Archives of Traditional Chinese Medicine | 2026, 44(9) : 81 - 85
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2026, 44(9): 81-85
• Target on National Project •
Research Progress on Mechanism of Sanqi (Panax notoginseng) Saponins in Treatment of Osteoporosis
Full
Peng WANG1, Longcan LI2, Fayan WEN2, Xingwen XIE3, Yanjun ZHANG1
Affiliations
  • 1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, Gansu, China
  • 2.Gansu University of Chinese Medicine, Lanzhou 730000, Gansu, China
  • 3.Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730030, Gansu, China
Published: 2026-09-10 doi: 10.13193/j.issn.1673-7717.2026.09.015
Outline
收藏切换

Osteoporosis (OP) is a systemic metabolic bone disease that causes bone loss over time and increases the risk of fracture, severely affecting patients' quality of life. However, there is still a lack of effective and safe targeted drugs. In recent years, some natural compounds have been favored by scholars due to their significant advantages of fewer adverse effects, obvious therapeutic effects and low economic costs. Sanqi (Panax notoginseng) saponins, an active ingredient of Sanqi (Panax notoginseng), a traditional medicinal plant, was found to be able to regulating various related signaling pathways such as mitogen-activated protein kinase (MAPK), Wnt/β-catenin, transforming growth factor β1 (TGF-β1)/Smads and RhoA/ROCK, Sanqi (Panax notoginseng) saponins can also control OP progression by regulating angiogenesis and lipid metabolism, promoting bone formation and inhibiting bone loss, and it is expected to be a potential therapeutic strategy for OP. Based on this, the authors briefly described the basic features of Sanqi (Panax notoginseng) saponins, and at the same time, the above mechanisms were specifically sorted out and elaborated, with a view to providing ideas and strategies for further research and treatment of Sanqi (Panax notoginseng) total saponins in the treatment of OP.

Sanqi (Panax notoginseng) saponins  /  osteoporosis  /  signaling pathway  /  angiogenesis  /  lipid metabolism
王鹏, 李茏灿, 温发延, 谢兴文, 张彦军. 三七总皂苷治疗骨质疏松症的机制研究进展. 中华中医药学刊, 2026 , 44 (9) : 81 -85 . DOI: 10.13193/j.issn.1673-7717.2026.09.015
Peng WANG, Longcan LI, Fayan WEN, Xingwen XIE, Yanjun ZHANG. Research Progress on Mechanism of Sanqi (Panax notoginseng) Saponins in Treatment of Osteoporosis[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (9) : 81 -85 . DOI: 10.13193/j.issn.1673-7717.2026.09.015
Year 2026 volume 44 Issue 9
90
16
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2026.09.015
  • Online Date:2026-10-20
  • Published:2026-09-10
Article Data
Affiliations
History
Funding
Affiliations
    1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, Gansu, China
    2.Gansu University of Chinese Medicine, Lanzhou 730000, Gansu, China
    3.Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730030, Gansu, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2026.09.015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT